Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
PetIQ Inc (PETQ) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Margin Expansion Amid Market Challenges
Discover how PetIQ Inc (PETQ) achieved a record-setting Q1 with significant increases in net sales, EPS, and adjusted EBITDA, alongside strategic insights into future market positioning. May 09, 2024
GuruFocus Research Drug Manufacturers
Supernus Pharmaceuticals Inc (SUPN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Capitalizing on Growth Opportunities
Despite a mixed financial performance, Supernus Pharmaceuticals Inc (SUPN) showcases strategic advancements and robust pipeline developments. May 09, 2024
GuruFocus Research Drug Manufacturers
Dynavax Technologies Corp (DVAX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Improved Financial Metrics
Explore the key financial outcomes and strategic insights from Dynavax Technologies Corp's first quarter of 2024, including significant revenue growth and enhanced gross margins. May 09, 2024
GuruFocus Research Drug Manufacturers
Verano Holdings Corp (VRNOF) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Capitalizing on Growth Opportunities
Despite a slight revenue dip, Verano Holdings Corp (VRNOF) showcases robust wholesale growth and strategic expansions in key cannabis markets. May 09, 2024